BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Business

  BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2023

  For more detail related to the fiscal year 2023 unaudited first quarter results, please visit BIOQUAL website.

  October 21, 2022

   · 

  1 min read
• Pharm Country

  Thubrikar Aortic Valve completes initial CE Mark-enabling TAVI-1 Study

  Thubrikar Aortic Valve, Inc., announced today that it has completed the initial CE Mark-enabling study using the Optimum Transcatheter Aortic Valve (Optimum TAV™) in patients with severe aortic stenosis.

  October 21, 2022

   · 

  3 min read
• Business

  Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast

  Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2022 financial results before market opening on Thursday, November 3, 2022.

  October 21, 2022

   · 

  2 min read
• FDA

  RINVOQ® (Upadacitinib) Receives Its Sixth U.S. FDA Approval

  AbbVie (NYSE: ABBV) today announces that the U.S. Food and Drug Administration (FDA) has approved RINVOQ®.

  October 21, 2022

   · 

  21 min read